# NeurAxis, Inc. (NRXS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NRXS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 3.65M | $ -7.99M | $ -6.62M | $ 416.6K | $ 3.40M |
| 2024 | $ 2.82M | $ -8.66M | $ -6.44M | $ 473.4K | $ 2.07M |
| 2023 | $ 2.66M | $ -19.84M | $ -7.27M | $ 224.3K | $ -1.40M |
| 2022 | $ 3.00M | $ -4.63M | $ -2.57M | $ 598.8K | $ -5.57M |
| 2021 | $ 554.8K | $ -1.01M | $ -234.2K | $ 439.3K | $ -825.7K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.12 |
| Liabilities / Eq | 0.88 |
| Current Ratio | 2.05 |

## Other views

- [Metrics](https://sponda.capital/en/NRXS.md)
- [Charts](https://sponda.capital/en/NRXS/charts.md)
- [Compare](https://sponda.capital/en/NRXS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.